Benzinga | Nov 5, 2021 09:42AM EDT

Crinetics Pharmaceuticals Q3 EPS $(0.73) Down From $(0.56) YoY

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.73) per share. This is a 30.36 percent decrease over losses of $(0.56) per share from the same period last year.